Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Cai Z, Zhu Z, Greene MI, Cines DB.

Autoimmun Rev. 2016 Jul;15(7):752-5. doi: 10.1016/j.autrev.2016.03.011. Epub 2016 Mar 9. Review.

PMID:
26970483
2.

The Role of Chemokines in Fibrotic Wound Healing.

Ding J, Tredget EE.

Adv Wound Care (New Rochelle). 2015 Nov 1;4(11):673-686. Review.

3.

The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control.

Hadjipanayi E, Kuhn PH, Moog P, Bauer AT, Kuekrek H, Mirzoyan L, Hummel A, Kirchhoff K, Salgin B, Isenburg S, Dornseifer U, Ninkovic M, Machens HG, Schilling AF.

PLoS One. 2015 Aug 28;10(8):e0135618. doi: 10.1371/journal.pone.0135618. eCollection 2015.

4.

Association between preeclampsia and the CXC chemokine family (Review).

Liu X, Dai LI, Zhou R.

Exp Ther Med. 2015 May;9(5):1572-1576. Epub 2015 Mar 9.

5.

Generation and Characterization of a New Monoclonal Antibody Against CXCL4.

Gao J, Wu M, Gao J, Wang X, Zhang Y, Zhu S, Yu Y, Han W.

Monoclon Antib Immunodiagn Immunother. 2015 Apr;34(2):110-5. doi: 10.1089/mab.2014.0050.

6.

Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis.

Zhang H, Ren Y, Tang X, Wang K, Liu Y, Zhang L, Li X, Liu P, Zhao C, He J.

Sci Rep. 2015 Mar 9;5:8888. doi: 10.1038/srep08888.

7.

The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.

Abu El-Asrar AM, Mohammad G, Nawaz MI, Abdelsaid M, Siddiquei MM, Alam K, Van den Eynde K, De Hertogh G, Opdenakker G, Al-Shabrawey M, Van Damme J, Struyf S.

Invest Ophthalmol Vis Sci. 2015 Feb 24;56(3):1956-64. doi: 10.1167/iovs.14-16144.

8.

Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.

Van Raemdonck K, Berghmans N, Vanheule V, Bugatti A, Proost P, Opdenakker G, Presta M, Van Damme J, Struyf S.

Oncotarget. 2014 Nov 15;5(21):10916-33.

9.

Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion.

Bruns I, Lucas D, Pinho S, Ahmed J, Lambert MP, Kunisaki Y, Scheiermann C, Schiff L, Poncz M, Bergman A, Frenette PS.

Nat Med. 2014 Nov;20(11):1315-20. doi: 10.1038/nm.3707. Epub 2014 Oct 19.

10.

Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.

Mukaida N, Sasaki S, Baba T.

Mediators Inflamm. 2014;2014:170381. doi: 10.1155/2014/170381. Epub 2014 May 22. Review.

11.

Effects of the C-terminal of endostatin on the tumorigenic potential of H22 cells.

Qi X, Liu Y, Wei W, Huang X, Zuo Y.

Biomed Rep. 2013 Sep;1(5):761-765. Epub 2013 Jul 22.

12.

Chemokines in tumor progression and metastasis.

Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS.

Oncotarget. 2013 Dec;4(12):2171-85. Review.

13.

Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer.

Mukaida N, Sasakki S, Popivanova BK.

Cancers (Basel). 2011 Jun 27;3(3):2811-26. doi: 10.3390/cancers3032811.

14.

Update on oncolytic viral therapy - targeting angiogenesis.

Tysome JR, Lemoine NR, Wang Y.

Onco Targets Ther. 2013 Jul 31;6:1031-40. doi: 10.2147/OTT.S46974. Print 2013.

15.

Macrophages and chemokines as mediators of angiogenesis.

Owen JL, Mohamadzadeh M.

Front Physiol. 2013 Jul 5;4:159. doi: 10.3389/fphys.2013.00159. eCollection 2013.

16.

Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology.

Pilatova K, Greplova K, Demlova R, Bencsikova B, Klement GL, Zdrazilova-Dubska L.

J Hematol Oncol. 2013 Jun 24;6:42. doi: 10.1186/1756-8722-6-42. Review.

17.

Platelet neuropeptide Y is critical for ischemic revascularization in mice.

Tilan JU, Everhart LM, Abe K, Kuo-Bonde L, Chalothorn D, Kitlinska J, Burnett MS, Epstein SE, Faber JE, Zukowska Z.

FASEB J. 2013 Jun;27(6):2244-55. doi: 10.1096/fj.12-213546. Epub 2013 Mar 1.

18.

One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.

Yang X, Hou J, Han Z, Wang Y, Hao C, Wei L, Shi Y.

Cell Biosci. 2013 Jan 21;3(1):5. doi: 10.1186/2045-3701-3-5.

19.

Heparin-induced thrombocytopenia in the pediatric population: a review of current literature.

Vakil NH, Kanaan AO, Donovan JL.

J Pediatr Pharmacol Ther. 2012 Jan;17(1):12-30. doi: 10.5863/1551-6776-17.1.12.

20.

Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.

Liang P, Cheng SH, Cheng CK, Lau KM, Lin SY, Chow EY, Chan NP, Ip RK, Wong RS, Ng MH.

Haematologica. 2013 Feb;98(2):288-95. doi: 10.3324/haematol.2012.065607. Epub 2012 Aug 28.

Items per page

Supplemental Content

Write to the Help Desk